ContraVir Pharmaceuticals, Inc. Pricing Underwritten Public Offering Of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Alaska LNG shipping savings justifies billions in investment, developer says
- Citi cuts investment banking analyst program to two years - Bloomberg
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Paramount Skydance to close WBD deal, change ticker to SKYD
ContraVir Pharma (CTRV) Prices Offering of Common Stock and Warrants
October 7, 2015 9:08 AM EDTContraVir Pharma (NASDAQ: CTRV) today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock and warrants to purchase up to 3,000,000 shares of the Company's common stock at a fixed combined price to the public of $3.00. The shares of common stock and warrants will be issued separately. The warrants will be exercisable for a period of five years following the issuance thereof at an exercise price of $4.25 per share. There is no established public trading... More



